Martinelli, Erika; Cremolini, Chiara; Mazard, Thibault; Vidal Barrull, Joana; Virchow, I.; Tougeron, David; Cuyle, Pieter-Jan; Chibaudel, Benoist; Kim, Stefano; Ghanem, Ismael; Asselain, Bernard; Castagné, Coline; Zkik, A.; Khan, S.; Arnold, Dirk
(Elsevier, 2022)
Background: BRAFV600E mutations occur in 8%-12% of metastatic colorectal cancer (mCRC) cases and are associated with poor survival. European guidelines recommend combination (doublet or triplet) chemotherapy plus bevacizumab ...
